Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Douglas W. McMillin
Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation
PLoS ONE
Multidisciplinary
Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
Seminars in Hematology
Hematology
Related publications
A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Frontiers in Oncology
Cancer Research
Oncology
Polo-Like Kinase 4 Inhibition: A Strategy for Cancer Therapy?
Cancer Cell
Cancer Research
Oncology
Cell Biology
Clinical Implications of Targeting XPO1-Mediated Nuclear Export in Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Clinical Research Protocols for Multiple Myeloma
Cancer Control
Medicine
Oncology
Hematology
Inhibition of Polo-Like Kinase 1 (Plk1) Enhances the Antineoplastic Activity of Metformin in Prostate Cancer
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Clinical Implications of Cytogenetic Heterogeneity in Multiple Myeloma Patients With TP53 Deletion
Modern Pathology
Forensic Medicine
Pathology
Downregulation of Human Polo-Like Kinase Activity by Antisense Oligonucleotides Induces Growth Inhibition in Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Enabling and Disabling Polo-Like Kinase 1 Inhibition Through Chemical Genetics
ACS Chemical Biology
Biochemistry
Medicine
Molecular Medicine
Inhibition of Polo-Like Kinase 2 Ameliorates Pathogenesis in Alzheimer’s Disease Model Mice
PLoS ONE
Multidisciplinary